Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 4/20 | 1.00 |
| ▸ | GLRA1 | P23415 | 3/20 | 1.00 |
| ▸ | GLRA2 | P23416 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | GUSB | P08236 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ginkolide B SCHEMBL13702797 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL464784 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL29495629 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL16407904 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL464783 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL14029435 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL29410795 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| Ginkolide B SCHEMBL14279903 | 1.00 | PTAFR (1.00) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| SCHEMBL13960075 | 0.94 | PTAFR (0.89) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 | |
| SCHEMBL13702667 | 0.94 | PTAFR (0.89) | PTAFRGLRA1GLRA2CYP2C9HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4088723-B1 | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN) | 2025-08-06 | — | — | EP | claimed |
| EP-4031182-A1 | ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF | Pharma Cosmetix Research, LLC (US) | 2022-07-27 | — | — | EP | claimed |
| US-20220202739-A1 | ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF | PHARMA COSMETIX RES LLC (US) | 2022-06-30 | — | — | US | claimed |
| EP-3958973-B1 | COMPOSITIONS FOR USE IN METHODS FOR IMPROVING SHORT-TERM MEMORY | CYTOSOLVE INC (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | AMYRIS INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4705495-A2 | METHODS FOR IMPROVED CELL CULTURE PERFORMANCE AND PRODUCT RECOVERY | Amyris, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12521365-B2 | Compositions for improving brain health and memory | CYTOSOLVE, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-12516090-B2 | Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds | Amyris, Inc. (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250368590-A1 | COMPOSITIONS AND METHODS FOR THE PURIFICATION OF ISOPRENOIDS | AMYRIS INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-12473556-B2 | Methods for stabilizing production of acetyl-coenzyme a derived compounds | Amyris, Inc. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12439922-B2 | Plant-based chemicals for Varroa mite control | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-10-14 | — | — | US | disclosed |
| WO-2022043407-A1 | COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | LAOUAREM YOUSRA (FR) | 2022-03-03 | — | — | WO | disclosed |
| EP-3958973-A1 | COMPOSITIONS FOR IMPROVING BRAIN HEALTH AND MEMORY | Cytosolve, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| US-11230716-B2 | Methods for stabilizing production of acetyl-coenzyme A derived compounds | Amyris, Inc. (US) | 2022-01-25 | — | — | US | disclosed |
| CN-111171043-B | Method for extracting ginkgolide B | 克拉玛依市人民医院 | 2020-10-30 | — | — | CN | disclosed |
| CN-111171043-A | Method for extracting ginkgolide B | 克拉玛依市人民医院 | 2020-05-19 | — | — | CN | disclosed |
| WO-2017133517-A1 | PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF | 四川海思科制药有限公司 | 2017-08-10 | — | — | WO | disclosed |
| WO-2016066100-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND ADP RECEPTOR ANTAGONIST, PREPARATION METHOD THEREOF AND USE THEREOF | 成都百裕科技制药有限公司 | 2016-05-06 | — | — | WO | disclosed |
| WO-2016066128-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND XA FACTOR INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF | 成都百裕科技制药有限公司 | 2016-05-06 | — | — | WO | disclosed |
| US-20110086119-A1 | Preparation for the relief of disease | AKL TECHNOLOGIES LIMITED | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | RHOA, NFATC1, CYP46A1 | PTAFR 2044/4885GLRA1 4756/4885GLRA2 4735/4885 |
| US-12439922-B2 | Plant-based chemicals for Varroa mite control | VARS1, CAT, API5 | PTAFR 4751/4885GLRA1 2448/4885GLRA2 2438/4885 |
| US-20110086119-A1 | Preparation for the relief of disease | F2, PLA2G7, ALOX15B | PTAFR 31/4885GLRA1 2293/4885GLRA2 3029/4885 |
| US-20250368590-A1 | COMPOSITIONS AND METHODS FOR THE PURIFICATION OF ISOPRENOIDS | GGPS1, HMGCR, DHCR7 | PTAFR 3632/4885GLRA1 4014/4885GLRA2 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.